CoChat

Risk stratification of cardiovascular and heart failure hospitalizations using integrated device diagnostics in patients with a cardiac resynchronization therapy defibrillator

Open access
Burri, Haran, da Costa, Antoine, Quesada, Aurelio, Ricci, Renato Pietro, Favale, Stefano, Clementy, Nicolas, Boscolo, Gabriele, Villalobos, Federico Segura, Mangoni di S. Stefano, Lorenza, Sharma, Vinod, Boriani, Giuseppe, On behalf of the MORE-CARE Investigators · 2018 · EP Europace
Cited by 46

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Aims: Cardiac resynchronization therapy defibrillators (CRT-D) are able to monitor various parameters that may be combined by an automatic algorithm to provide a heart failure risk status (HFRS). We sought to validate the HFRS for stratifying patient risk, evaluate its association with heart failure (HF) symptoms, and investigate its utility for triage of automatic alerts. Methods and results: Data from 722 patients included in the MORE-CARE trial were analysed in a post hoc analysis. A high HFRS was associated with a significantly increased risk of admission over the next 30 days with a relative risk for cardiovascular hospitalization (CVH) of 4.5 (95% CI: 3.1-6.6, P < 0.001), of HF hospitalization of 6.3 (95% CI: 3.9-10.2, P < 0.001) and of non-HF related CVH of 3.5 (95% CI: 2.0-6.9, P < 0.001). The negative predictive value of low or medium HFRS for these admissions was ≥98%. A high HFRS was associated with an increased risk of HF symptoms. Of all the automatic remote monitoring alerts generated during the study, only 10% had a high HFRS. Conclusion: The HFRS is able to risk-stratify CRT-D patients, which is potentially useful for managing automatic remote monitoring alerts, by focusing attention on the minority of high-risk patients. Clinical Trial Registration: The trial was registered at www.clinicaltrials.gov under number NCT00885677.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/europace/eux206

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 14

  1. Whellan, 2010, Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study, J Am Coll Cardiol, 55, 1803
  2. Perego, 2008, Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization, J Interv Card Electrophysiol, 23, 235
  3. Cowie, 2013, Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting, Eur Heart J, 34, 2472
  4. Gula, 2014, A novel algorithm to assess risk of heart failure exacerbation using ICD diagnostics: validation from RAFT, Heart Rhythm, 11, 1626
  5. Burri, 2010, The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) study: rationale and design, Am Heart J, 160, 42
  6. Boriani, 2013, The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring, J Med Internet Res, 15, e167.
  7. Boriani, 2016, Effects of remote monitoring on outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of MORE-CARE, a multi-centre randomized controlled trial, Eur J Heart Fail, 19, 416
  8. Mairesse, 2015, Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association, Europace, 17, 814
  9. Morgan, 2017, Remote management of heart failure using implantable electronic devices, Eur Heart J
  10. Parthiban, 2015, Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes, J Am Coll Cardiol, 65, 2591
  11. Tang, 2012, Threshold crossing of device-based intrathoracic impedance trends identifies relatively increased mortality risk, Eur Heart J, 33, 2189
  12. Böhm, 2016, Fluid status telemedicine alerts for heart failure: a randomized controlled trial, Eur Heart J, 37, 3154
  13. Small, 2009, Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert, J Card Fail, 15, 475
  14. Zile, 2016, Prediction of all-cause mortality based on the direct measurement of intrathoracic impedance, Circ Heart Fail, 9, e002543

Cited by

See all 46

Metadata

Authors
Burri, H., da Costa, A., Quesada, A., Ricci, R. P., Favale, S., Clementy, N., Boscolo, G., Villalobos, F. S., Mangoni di S. Stefano, L., Sharma, V., Boriani, G., & On behalf of the MORE-CARE Investigators
Venue
EP Europace
Published
2017-06-30
Volume
20
Issue
5
Pages
e69-e77
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W2727566622
Cited by
46
References
1
FWCI
2.17
Type
journal article
Language
en
Open access
bronze
Funders
Medtronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.